Patents by Inventor Wikanda TECHANAN

Wikanda TECHANAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220411745
    Abstract: The present invention discloses a genetically engineered Kluyveromyces sp. yeast cell comprising at least a genetic modification that inactivates or deletes a nucleic acid sequence encoding for transcription factor SEQ ID No. 2, particularly Haal. The genetically engineered yeast cell according to this invention has an improvement of lactic acid tolerance, lactic acid production or a combination thereof as compared to the parental.
    Type: Application
    Filed: August 19, 2019
    Publication date: December 29, 2022
    Applicant: PTT Global Chemical Public Company Limited
    Inventors: Phatthanon Prasitchoke, Natthawut Poomsila, Kraileark Kittisuriyanont, Narong Kaewsuwan, Wikanda Techanan
  • Patent number: 11242507
    Abstract: The present invention relates to a novel mutant strain Aspergillus aculeatus E14-292 and a genetic modification process of said strain, wherein the mutant strain according to this invention can produce cellulase and xylanase more than the BCC199 (wild type). Moreover, the obtained enzymes can be used to digest the pretreatment bagasse to further produce sugars effectively.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: February 8, 2022
    Assignee: PTT Global Chemical Public Company Limited
    Inventors: Verawat Champreda, Surisa Suwannarangsee, Jantima Arnthong, Chatuphon Siamphan, Aphisit Poonsrisawat, Napong Ketsub, Mahattanee Phinyo, Wikanda Techanan, Natthawut Poomsila, Phatthanon Prasitchoke
  • Patent number: 11236375
    Abstract: The present invention relates to a novel mutant strain Clostridium thermocellum M2_15-C8 and a genetic modification process of said bacteria, wherein the mutant strain according to this invention can produce cellulase and xylanase more than the wild type. Moreover, the obtained enzymes can be used to digest the pretreated bagasse to further produce sugars effectively.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: February 1, 2022
    Assignee: PTT Global Chemical Public Company Limited
    Inventors: Chakrit Tachaapaikoon, Khanok Ratanakhanokchai, Patthra Pason, Rattiya Waeonukul, Prattana Ketbot, Wikanda Techanan, Kraileark Kittisuriyanont, Narong Kaewsuwan
  • Publication number: 20210095242
    Abstract: The present invention relates to a novel mutant strain Aspergillus aculeatus E14-292 and a genetic modification process of said strain, wherein the mutant strain according to this invention can produce cellulase and xylanase more than the BCC199 (wild type). Moreover, the obtained enzymes can be used to digest the pretreatment bagasse to further produce sugars effectively.
    Type: Application
    Filed: May 30, 2018
    Publication date: April 1, 2021
    Applicant: PTT Global Chemical Public Company Limited
    Inventors: Verawat CHAMPREDA, Surisa SUWANNARANGSEE, Jantima ARNTHONG, Chatuphon SIAMPHAN, Aphisit POONSRISAWAT, Napong KETSUB, Mahattanee PHINYO, Wikanda TECHANAN, Natthawut POOMSILA, Phatthanon PRASITCHOKE
  • Publication number: 20210079434
    Abstract: The present invention relates to a novel mutant strain Clostridium thermocellum M2_15-C8 and a genetic modification process of said bacteria, wherein the mutant strain according to this invention can produce cellulase and xylanase more than the wild type. Moreover, the obtained enzymes can be used to digest the pretreated bagasse to further produce sugars effectively.
    Type: Application
    Filed: May 30, 2018
    Publication date: March 18, 2021
    Applicant: PTT Global Chemical Public Company Limited
    Inventors: Chakrit TACHAAPAIKOON, Khanok RATANAKHANOKCHAI, Patthra PASON, Rattiya WAEONUKUL, Prattana KETBOT, Wikanda TECHANAN, Kraileark KITTISURIYANONT, Narong KAEWSUWAN